Refining immunosuppressive protocols in pediatric renal transplant recipients

By Hoyer P.F.   Vester U.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3587-3589

Elsevier

Access to resources Recommend Favorite

Lipid metabolism and immunosuppressive therapy in heart transplant recipients

By Berman M.   Ben-Gal T.   Stamler A.   Kogan A.   Shapira Y.   Sagie A.   Saute M.   Kramer M.   Aravot D.   Vidne B.   Sahar G.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 677-677

Elsevier

Access to resources Recommend Favorite

C 2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients

By Weber L.T.   Shipkova M.   Armstrong V.W.   Mehls O.   Oellerich M.   Tonshoff B.   German Study Group Pediatric Renal Transplantation  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2128-2130

Elsevier

Access to resources Recommend Favorite

Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?

By Jensen P.   Hansen S.   Moller B.   Leivestad T.   Pfeffer P.   Fauchald P.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1120-1120

Elsevier

Access to resources Recommend Favorite

Effect of folic acid therapy on serum homocysteine level in renal transplant recipients

By Savaj S.   Rezakhani S.   Porooshani F.   Ghods A.J.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2419-2419

Elsevier

Access to resources Recommend Favorite